The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

HCC Profiles

Hepatocellular carcinoma (HCC) requires thorough evaluation of the tumor stage to ensure precise prognosis and clear treatment recommendations, including consideration of liver transplantation. To achieve this goal, patient assessment must be based on both radiological and clinical parameters. The new HCC staging support in mint Lesion™ 3.0 therefore allows to easily capture a number of relevant imaging parameters (e.g. size, number, vascular invasion) and clinical data (e.g. Child-Pugh score and Performance Status). Based on these parameters, mint Lesion™ 3.0 automatically derives BCLC and TNM staging as well as liver transplantation recommendations according to Milan or UCSF criteria.

 

Related Resources

Related Resources

6 years of Mint at University Hospital Basel - Interview with PD Dr. Tobias Heye

Since the end of 2011, mint Lesion™ has been in use at the University Hospital in Basel, Switzerland, – initially merely as a tool for clinical…

University Hospital Ulm: Pilot study shows discriminatory power of MRI-based 3d texture analysis for bone lesions

Distinguishing between enchondroma, a benign tumor, and low-grade chondrosarcoma, which is a low-aggressivity malignancy, is a frequent challenge, as…

4 Questions – 4 Answers // Imaging in Clinical Trials

Mint Medical, Inc. Vice President of Clinical Trials, Kelie Luby Discusses Advances in Imaging Analysis in Clinical Trials and What’s Next for Mint…